Denosumab HALTs bone loss during AI therapy for breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Denosumab does the trick for bone loss in breast cancer

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Risedronic acid prevents bone loss in postmenopausal women with breast cancer, with or without aromatase inhibitor (AI) therapy,

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Calcium + vitamin D combo halts bone loss in elderly women

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Therapy for Menopausal Symptoms During and After Treatment for Breast Cancer: Safety Considerations

By Baber Rodney Hickey Martha

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1085-1100

Adis International

Access to resources Recommend Favorite